Live Breaking News & Updates on Teva Europe Commercial

Stay updated with breaking news from Teva europe commercial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Teva Pharmaceutical Industries Limited: United Kingdom first to grant licence for Teva's ophthalmology biosimilar Ongavia (ranibizumab)?

MHRA today granted a licence for Ongavia (ranibizumab), a biosimilar to Lucentis , for the treatment of (wet) age-related macular degeneration (AMD) and several other eye diseases, such as diabetic ....

United Kingdom , Frankg Holz , Piotr Oleksy , Federico Ricci , Joachim Kiefer , Richard Daniell , Peterk Kaiser , Steffen Schmitz Valckenberg , John Lowe , United Kingdom Medicines Healthcare Regulatory Agency , Polpharma Biologics Group , Study Group Efficacy , Genentech Inc , Formycon Group , Experimental Eye Research , Teva Pharmaceutical Industries Ltd , Pharmaceutical Industries Ltd , Executive Vice President , Teva Europe Commercial , Pharmaceutical Industries , Group Efficacy , Neovascular Age Related Macular Degeneration , British Journal , Private Securities Litigation Reform Act , Quarterly Report , Annual Report ,